The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide
- 19 December 2003
- journal article
- review article
- Published by Elsevier BV in Progress in Biophysics and Molecular Biology
- Vol. 84 (2-3), 217-232
- https://doi.org/10.1016/j.pbiomolbio.2003.11.010
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Simvastatin Normalizes Autonomic Neural Control in Experimental Heart FailureCirculation, 2003
- Overexpression of eNOS in RVLM Improves Impaired Baroreflex Control of Heart Rate in SHRSPHypertension, 2003
- Neuroprotection mediated by changes in the endothelial actin cytoskeletonJCI Insight, 2000
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.JCI Insight, 1998
- Peripheral chemoreflex in chronic heart failure: Friend and foeAmerican Heart Journal, 1996
- Sympathetically Mediated Hypertension Caused by Chronic Inhibition of Nitric OxideHypertension, 1995
- Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans?Hypertension, 1994
- Nitrosyl factors mediate active neurogenic hindquarter vasodilation in the conscious rat.Hypertension, 1994
- Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs.Hypertension, 1993
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.Cell Metabolism, 1981